Tego Science, Inc.
Quick facts
Phase 3 pipeline
- TPX-105 · Pain Management
TPX-105 is a selective inhibitor of transient receptor potential (TRP) channels involved in pain signaling. - TPX-114 · Oncology
TPX-114 is a small molecule inhibitor of the CDK9 enzyme.